During the past decade, Tekton Research conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tekton Research" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Novavax" with 2 trials sponsored, "Affinivax, Inc." with 1 trials sponsored, "American Regent, Inc." with 1 trials sponsored and "Inovio Pharmaceuticals" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tekton Research" #1 collaborator was "Advaccine (Suzhou) Biopharmaceuticals Co., Ltd." with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Children's Hospital Medical Center, Cincinnati" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "University of Chicago" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Tekton Research" are "COVID-19" (2 trials), "Influenza" (2 trials), "Asthma in Children" (1 trials), "Bronchiolitis" (1 trials) and "Bronchitis" (1 trials). Many other conditions were trialed in "Tekton Research" in a lesser frequency.

Most popular intervention types in "Tekton Research" are "Drug" (5 trials), "Biological" (4 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Baloxavir Marboxil" (2 trials), "AFX3772" (1 trials), "Biological/Vaccine: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)" (1 trials) and "CELLECTRA® 2000" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tekton Research" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Tekton Research". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Tekton Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tekton Research, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".